Roche joins race for obesity drugs with USD 2.7 billion Carmot deal Ruchika Sharma5 Dec 2023 8:00 AM GMTRoche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of contestants seeking to...
CDSCO Panel approves Roche's PMS Study Report of Rituximab with Glucocorticoids in Wegener's Granulomatosis Dr. Divya Colin3 Dec 2023 11:45 AM GMTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved a post-marketing...
Roche launches Elecsys HBeAg quant for hepatitis B infection Ruchika Sharma28 Nov 2023 6:28 AM GMTIt can also simplify the experience for patients, as they only have to undergo one single test to indicate both the presence and quantity of HBeAg.
Roche subcutaneous injection of Tecentriq recommended by EU CHMP for multiple cancer types Ruchika Sharma19 Nov 2023 4:30 AM GMTBasel: Roche has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of...
Roche unveils Elecsys Anti-HEV IgM, Elecsys Anti-HEV IgG immunoassays for hepatitis E virus infection detection Ruchika Sharma18 Nov 2023 4:30 AM GMTBasel: Roche has announced the launch of the Elecsys Anti-HEV IgM and Elecsys Anti-HEV IgG immunoassays for the detection of hepatitis E virus (HEV)...
Rznomics enters clinical trial collaboration with Roche to evaluate RZ-001 in combo with anti-PDL1 in liver cancer patients Ruchika Sharma15 Nov 2023 6:00 AM GMTSeongnam: Rznomics Inc., a South Korea based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, has...
Roche receives USFDA Breakthrough Device Designation for Multiple Sclerosis test Elecsys NfL Ruchika Sharma10 Nov 2023 7:00 AM GMTElecsys NfL has the potential to help laboratories to scale MS testing on widely available, fully automated and standardised Roche cobas instruments...
Roche gets CDSCO panel Nod To study safety, and efficacy of Faricimab Intravitreal injection Dr. Divya Colin29 Oct 2023 12:30 PM GMTNew Delhi: The drug major Roche has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Roche bags USFDA nod for Vabysmo to treat retinal vein occlusion Ruchika Sharma27 Oct 2023 6:02 AM GMT"Vabysmo is a new treatment option for RVO that can help people preserve and improve their vision, with the added benefit of retinal drying," said...
Roche settles patent lawsuit against Biogen over biosimilar version of rheumatoid arthritis drug Actemra Ruchika Sharma26 Oct 2023 8:00 AM GMTBasel: Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of...
Roche acquires Telavant Holdings for USD 7.1 billion Ruchika Sharma24 Oct 2023 7:00 AM GMTBasel: Roche has announced the entry into a definitive agreement to acquire Telavant Holdings, Inc., a Roivant company, owned by Roivant Sciences Ltd....
Royalty Pharma to pay USD 1 billion for Roche SMA drug royalties Ruchika Sharma22 Oct 2023 4:30 AM GMTPTC said it plans to use the proceeds from the deal to pay back its debt from Blackstone Life Sciences and to fund planned operations.
